Cary Street Partners Financial LLC dramatically reduced its stake in Regeneron Pharmaceuticals. The firm now holds a mere 255 ...

Michael Burry's Scion Asset Management switched out a bet against Nvidia for a wager on Meta as it overhauled its stock ...

Detailed price information for Phathom Pharmaceuticals Inc (PHAT-Q) from The Globe and Mail including charting and trades.

Michael Burry's Scion Asset Management ended the first quarter more bullish on companies across different sectors and ...

Scion Asset Management, founded by Michael Burry of "Big Short" fame, started new positions in consumer and healthcare names including lululemon athletica (LULU ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

We closed out July 2025 in Boston alongside several of our Axinn colleagues attending the American Conference Institute’s ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large-cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Swiss National Bank trimmed its stake in Regeneron Pharmaceuticals, Inc. by a modest 0.5%. Despite this, Regeneron's share ...